Daniel R. Chevallard - Insider Trading & Ownership

Entity
Individual
Location
C/O Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego, CA
Summary
The estimated net worth of Daniel R. Chevallard is at least $98.5K dollars as of January 13, 2025. Daniel R. Chevallard is the CFO and COO of Viracta Therapeutics, Inc. and owns shares of Viracta Therapeutics, Inc. (VIRX) stock worth about $91.9K. Daniel R. Chevallard is the Chief Financial Officer of LENZ Therapeutics, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $6.63K.
All Insider Reports
All Insider Reports

Ownership of Daniel R. Chevallard

Insider Transactions Reported by Daniel R. Chevallard:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.